PALI
Palisade Bio Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.94
-0.09 ▼ -4.43%
🌙 3월 13일 7:34 PM ET (한국 3/14 08:34)
$1.95
+0.01 ▲ +0.52%
| Index | - | P/E | - | EPS (ttm) | -4.22 | Insider Own | 3.75% | Shs Outstand | 0.15B | Perf Week | 19.02% |
| Market Cap | 0.29B | Forward P/E | - | EPS next Y | 53.07% | Insider Trans | 0.07% | Shs Float | 0.14B | Perf Month | 11.49% |
| Enterprise Value | 0.28B | PEG | - | EPS next Q | -0.04 | Inst Own | 91.11% | Short Float | 18.64% | Perf Quarter | -7.62% |
| Income | -0.01B | P/S | - | EPS this Y | 94.56% | Inst Trans | 163.13% | Short Ratio | 5.8 | Perf Half Y | 233.33% |
| Sales | 0.00B | P/B | 5.51 | EPS next 5Y | 67.97% | ROA | -137.67% | Short Interest | 26.73M | Perf YTD | -17.45% |
| Book/sh | 0.35 | P/C | 55.27 | EPS past 3/5Y | 84.12% 77.35% | ROE | -228.64% | 52W High | -26.52% ($2.64) | Perf Year | 111.44% |
| Cash/sh | 0.04 | P/FCF | - | Sales past 3/5Y | - | ROIC | -349.5% | 52W Low | 266.04% ($0.53) | Perf 3Y | -93.93% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 71.95% | Gross Margin | - | Volatility(W/M) | 8.3% 7.08% | Perf 5Y | -99.97% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.14 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 1.78 | EPS Q/Q | 83.49% | Profit Margin | - | RSI (14) | 57.14 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.78 | Sales Q/Q | - | SMA20 | 9.57% ($1.77) | Beta | 1.36 | Target Price | $13 |
| Payout | - | Debt/Eq | 0.07 | Earnings | 2025/11/17 | SMA50 | 7.72% ($1.8) | Rel Volume | 0.67 | Prev Close | $2.03 |
| Employees | 8 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -29.03% - | SMA200 | 40.25% ($1.38) | Avg Volume(3M) | 4.61M | Price | $1.94 |
| IPO | 2006/12/20 | Option/Short | No/Yes | Trades | 5493 | Volume | 3,104,998 | Change | -4.43% |
뉴스 로딩 중...